Biotech Business - December 14, 2017
New results from Immuneed
Biotech company Immuneed has published two scientific publications, supporting both its immuno-service and its immuno-oncology offerings. The articles demonstrate Immuneed’s whole blood loop assay, a tool to predict first-infusion reactions of immunotherapeutics1, and a novel targeting and adjuvant strategy to improve T cell responses that can be used for cancer vaccines. “When performing preclinical safety […]
CRO - September 13, 2016
Immuneed secures SEK 4.3M in financing
Immuneed secures SEK 4.3M in seed financing to further develop its immuno-oncology cancer vaccine candidate and grow its human whole-blood loop service for detection of acute immune related side effects of biopharmaceuticals. After Immuneed’s establishment in 2014 and early funding from Bio-X (Uppsala Bio/VINNOVA) and the Dutch Technology Foundation STW, Immuneed has secures SEK 4.3M […]